• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与髓系来源抑制细胞(MDSC)调控的信号通路。

Signaling pathways involved in MDSC regulation.

作者信息

Trikha Prashant, Carson William E

机构信息

Comprehensive Cancer Center, The Ohio State University, USA.

Comprehensive Cancer Center, The Ohio State University, USA; Department of Surgery, The Ohio State University, Columbus, OH 43210, USA.

出版信息

Biochim Biophys Acta. 2014 Aug;1846(1):55-65. doi: 10.1016/j.bbcan.2014.04.003. Epub 2014 Apr 13.

DOI:10.1016/j.bbcan.2014.04.003
PMID:24727385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4140957/
Abstract

The immune system has evolved mechanisms to protect the host from the deleterious effects of inflammation. The generation of immune suppressive cells like myeloid derived suppressor cells (MDSCs) that can counteract T cell responses represents one such strategy. There is an accumulation of immature myeloid cells or MDSCs in bone marrow (BM) and lymphoid organs under pathological conditions such as cancer. MDSCs represent a population of heterogeneous myeloid cells comprising of macrophages, granulocytes and dendritic cells that are at early stages of development. Although, the precise signaling pathways and molecular mechanisms that lead to MDSC generation and expansion in cancer remains to be elucidated. It is widely believed that perturbation of signaling pathways involved during normal hematopoietic and myeloid development under pathological conditions such as tumorogenesis contributes to the development of suppressive myeloid cells. In this review we discuss the role played by key signaling pathways such as PI3K, Ras, Jak/Stat and TGFb during myeloid development and how their deregulation under pathological conditions can lead to the generation of suppressive myeloid cells or MDSCs. Targeting these pathways should help in elucidating mechanisms that lead to the expansion of MDSCs in cancer and point to methods for eliminating these cells from the tumor microenvironment.

摘要

免疫系统已经进化出保护宿主免受炎症有害影响的机制。产生能够抵消T细胞反应的免疫抑制细胞,如髓系来源的抑制细胞(MDSCs),就是这样一种策略。在癌症等病理条件下,骨髓(BM)和淋巴器官中会积累未成熟的髓系细胞或MDSCs。MDSCs代表一群异质性的髓系细胞,包括处于发育早期的巨噬细胞、粒细胞和树突状细胞。尽管导致癌症中MDSC产生和扩增的确切信号通路和分子机制仍有待阐明。人们普遍认为,在肿瘤发生等病理条件下,正常造血和髓系发育过程中涉及的信号通路受到干扰会导致抑制性髓系细胞的产生。在这篇综述中,我们讨论了PI3K、Ras、Jak/Stat和TGFb等关键信号通路在髓系发育过程中所起的作用,以及它们在病理条件下的失调如何导致抑制性髓系细胞或MDSCs的产生。针对这些通路应该有助于阐明导致癌症中MDSCs扩增的机制,并指出从肿瘤微环境中消除这些细胞的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0036/4140957/5d0cfd852e1b/nihms590652f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0036/4140957/e2ebb2a7144f/nihms590652f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0036/4140957/5d0cfd852e1b/nihms590652f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0036/4140957/e2ebb2a7144f/nihms590652f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0036/4140957/5d0cfd852e1b/nihms590652f2.jpg

相似文献

1
Signaling pathways involved in MDSC regulation.参与髓系来源抑制细胞(MDSC)调控的信号通路。
Biochim Biophys Acta. 2014 Aug;1846(1):55-65. doi: 10.1016/j.bbcan.2014.04.003. Epub 2014 Apr 13.
2
Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.髓源性抑制细胞:肿瘤微环境中驱动免疫抑制的关键细胞
Adv Cancer Res. 2015;128:95-139. doi: 10.1016/bs.acr.2015.04.002. Epub 2015 May 12.
3
Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways.髓源性抑制细胞和耐受原性树突状细胞是由 PI3K 和 Wnt 信号通路分别诱导的。
J Biol Chem. 2023 Nov;299(11):105276. doi: 10.1016/j.jbc.2023.105276. Epub 2023 Sep 20.
4
The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.髓系来源抑制细胞的发育与归巢:从两阶段模型到多步骤叙述。
Front Immunol. 2020 Oct 26;11:557586. doi: 10.3389/fimmu.2020.557586. eCollection 2020.
5
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis.髓源性抑制细胞的发育受 STAT/IRF-8 轴的调节。
J Clin Invest. 2013 Oct;123(10):4464-78. doi: 10.1172/JCI68189. Epub 2013 Sep 16.
6
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.S100A9蛋白可调节癌症中树突状细胞分化的抑制以及髓源性抑制细胞的积累。
J Exp Med. 2008 Sep 29;205(10):2235-49. doi: 10.1084/jem.20080132. Epub 2008 Sep 22.
7
Myeloid-Derived Suppressor Cells and Proinflammatory Cytokines as Targets for Cancer Therapy.髓源性抑制细胞和促炎细胞因子作为癌症治疗的靶点
Biochemistry (Mosc). 2016 Nov;81(11):1274-1283. doi: 10.1134/S0006297916110055.
8
Down-regulation of PLCγ2-β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer.PLCγ2-β-连环蛋白通路的下调促进了癌症中髓源性抑制细胞的激活和扩增。
J Exp Med. 2013 Oct 21;210(11):2257-71. doi: 10.1084/jem.20130281. Epub 2013 Oct 14.
9
IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer.IRF7 通过 S100A9 反式转录抑制在癌症中调节粒细胞髓系来源的抑制细胞的发育。
Oncogene. 2017 May 25;36(21):2969-2980. doi: 10.1038/onc.2016.448. Epub 2017 Jan 16.
10
Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.上调的髓源性抑制细胞通过损害树突状细胞功能促进肝细胞癌的发展。
Scand J Gastroenterol. 2011 Feb;46(2):156-64. doi: 10.3109/00365521.2010.516450. Epub 2010 Sep 7.

引用本文的文献

1
[Exploring the Causal Relationship Between Circulating Immune Cells and Autoimmune Hepatitis Through Mendelian Randomization Analysis].[通过孟德尔随机化分析探索循环免疫细胞与自身免疫性肝炎之间的因果关系]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):425-433. doi: 10.12182/20250360201.
2
Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches.癌症治疗中的炎症靶向:从机制洞察到新兴治疗方法
J Transl Med. 2025 May 26;23(1):588. doi: 10.1186/s12967-025-06583-3.
3
Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes.

本文引用的文献

1
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis.髓源性抑制细胞的发育受 STAT/IRF-8 轴的调节。
J Clin Invest. 2013 Oct;123(10):4464-78. doi: 10.1172/JCI68189. Epub 2013 Sep 16.
2
A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma.唑来膦酸作为可切除性胰腺导管腺癌患者新辅助围手术期治疗的研究
J Cancer Ther. 2013 May;4(3):797-803. doi: 10.4236/jct.2013.43096.
3
Pancreatic cancer-associated stellate cells: A viable target for reducing immunosuppression in the tumor microenvironment.
由不同髓系表型驱动的转移性三阴性乳腺癌对免疫检查点抑制的反应
Commun Med (Lond). 2025 May 17;5(1):180. doi: 10.1038/s43856-025-00860-4.
4
Single-cell transcriptomic analysis identified resistant MDSCs and a stress-tolerant gene co-expression network as common MDSC features across multiple disease settings.单细胞转录组分析确定了抗性髓系来源抑制细胞(MDSCs)和一个应激耐受基因共表达网络,作为多种疾病背景下MDSCs的共同特征。
Front Immunol. 2025 Apr 8;16:1565211. doi: 10.3389/fimmu.2025.1565211. eCollection 2025.
5
The role of immunotherapy in targeting tumor microenvironment in genitourinary cancers.免疫疗法在靶向泌尿生殖系统癌症肿瘤微环境中的作用。
Front Immunol. 2025 Apr 7;16:1506278. doi: 10.3389/fimmu.2025.1506278. eCollection 2025.
6
MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy.髓源性抑制细胞(MDSC)检查点阻断疗法:癌症免疫治疗中克服免疫抑制的新突破点。
Cancer Gene Ther. 2025 Apr;32(4):371-392. doi: 10.1038/s41417-025-00886-9. Epub 2025 Mar 26.
7
Oncogenic Mutations and the Tumor Microenvironment: Drivers of Non-Small Cell Lung Cancer Progression.致癌突变与肿瘤微环境:非小细胞肺癌进展的驱动因素
Cancers (Basel). 2025 Mar 1;17(5):853. doi: 10.3390/cancers17050853.
8
Insights into CSF-1R Expression in the Tumor Microenvironment.对肿瘤微环境中集落刺激因子1受体(CSF-1R)表达的见解。
Biomedicines. 2024 Oct 18;12(10):2381. doi: 10.3390/biomedicines12102381.
9
CCL9/CCR1 axis-driven chemotactic nanovesicles for attenuating metastasis of SMAD4-deficient colorectal cancer by trapping TGF-.CCL9/CCR1轴驱动的趋化纳米囊泡,通过捕获转化生长因子β来减轻SMAD4缺陷型结直肠癌的转移
Acta Pharm Sin B. 2024 Aug;14(8):3711-3729. doi: 10.1016/j.apsb.2024.05.009. Epub 2024 May 11.
10
Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives.赖氨酸甲基化修饰在肿瘤免疫调节和免疫治疗中的作用:调控机制与展望
Biomark Res. 2024 Jul 30;12(1):74. doi: 10.1186/s40364-024-00621-w.
胰腺癌相关星状细胞:降低肿瘤微环境中免疫抑制作用的可行靶点。
Oncoimmunology. 2013 Jul 1;2(7):e24891. doi: 10.4161/onci.24891. Epub 2013 May 7.
4
New roles of Rb1 in expansion of MDSCs in cancer.Rb1在癌症中髓源性抑制细胞扩增中的新作用。
Cell Cycle. 2013 May 1;12(9):1329-30. doi: 10.4161/cc.24577. Epub 2013 Apr 11.
5
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients.STAT3 调控癌症患者来源的髓系来源抑制细胞中的精氨酸酶-I。
J Clin Invest. 2013 Apr;123(4):1580-9. doi: 10.1172/JCI60083.
6
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.抑癌基因视网膜母细胞瘤的表观遗传沉默调控肿瘤中髓系细胞的病理性分化。
Nat Immunol. 2013 Mar;14(3):211-20. doi: 10.1038/ni.2526. Epub 2013 Jan 27.
7
A novel strategy for modulation of MDSC to enhance cancer immunotherapy.一种调节髓源性抑制细胞以增强癌症免疫治疗的新策略。
Oncoimmunology. 2012 Sep 1;1(6):984-985. doi: 10.4161/onci.20201.
8
Colony stimulating factors and myeloid cell biology in health and disease.集落刺激因子与髓系细胞生物学:基础与临床
Trends Immunol. 2013 Feb;34(2):81-9. doi: 10.1016/j.it.2012.08.006. Epub 2012 Sep 21.
9
Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells.荷瘤小鼠来源的髓源性抑制细胞可破坏 TGF-β诱导的 CD4+CD25-FoxP3- T 细胞向 CD4+CD25+FoxP3+ Tregs 的分化。
J Leukoc Biol. 2012 Nov;92(5):987-97. doi: 10.1189/jlb.0911465. Epub 2012 Aug 13.
10
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.单次剂量环磷酰胺后,IMA901 癌症疫苗的多肽免疫反应与患者更长的生存时间相关。
Nat Med. 2012 Aug;18(8):1254-61. doi: 10.1038/nm.2883. Epub 2012 Jul 29.